Soojin Kim Selected Research

Acidic Amino Acids

1/2021	Preparation and Evaluation of Colon-Targeted Prodrugs of the Microbial Metabolite 3-Indolepropionic Acid as an Anticolitic Agent.
9/2020	A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats.
1/2019	Colon-Targeted Delivery Facilitates the Therapeutic Switching of Sofalcone, a Gastroprotective Agent, to an Anticolitic Drug via Nrf2 Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Soojin Kim Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 12/2004
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2013
6	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2022 - 10/2002
6	Colitis 01/2021 - 01/2019
5	Inflammation (Inflammations) 01/2022 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 10/2002
3	Infections 01/2021 - 01/2017
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2020 - 07/2016
2	Ischemia 09/2022 - 01/2018
2	Cholestasis 01/2022 - 01/2018
2	Cicatrix (Scar) 09/2021 - 09/2020
2	Brain Injuries (Brain Injury) 09/2021 - 05/2019
2	Bone Resorption 07/2021 - 09/2020
2	Hepatocellular Carcinoma (Hepatoma) 05/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2016
2	Brain Ischemia (Cerebral Ischemia) 08/2017 - 08/2017
2	Tuberculosis (Tuberculoses) 10/2016 - 08/2016
2	Disease Progression 01/2015 - 10/2014
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2014 - 10/2005
1	Low Tension Glaucoma 03/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Malaria 11/2021
1	Osteoporosis 07/2021
1	Osteitis 07/2021
1	Chemical and Drug Induced Liver Injury 05/2021
1	Spinal Dysraphism (Spina Bifida) 01/2021
1	Urinary Incontinence 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Bites and Stings (Sting) 01/2020

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2002
6	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 11/2013
5	Pharmaceutical PreparationsIBA 11/2021 - 10/2016
4	AcidsIBA 01/2021 - 01/2019
4	CytokinesIBA 01/2020 - 07/2016
3	AntigensIBA 09/2021 - 08/2016
3	Acidic Amino AcidsIBA 01/2021 - 01/2019
3	enzalutamideIBA 01/2016 - 01/2015
2	OsteopontinIBA 09/2022 - 05/2019
2	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2018
2	Sulfonic AcidsIBA 01/2021 - 12/2019
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2021 - 01/2019
2	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2021 - 11/2019
2	Glutamic Acid (Glutamate)FDA Link 09/2020 - 01/2019
2	ProdrugsIBA 09/2020 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2016
2	Neuroprotective AgentsIBA 08/2017 - 08/2017
2	Phosphotransferases (Kinase)IBA 07/2016 - 06/2015
2	AndrogensIBA 01/2016 - 11/2013
2	capivasertibIBA 06/2015 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 10/2014
1	Periodic AcidIBA 09/2022
1	UbiquitinIBA 09/2022
1	Glycoproteins (Glycoprotein)IBA 09/2022
1	sovesudilIBA 03/2022
1	rho-Associated KinasesIBA 03/2022
1	Protein Kinases (Protein Kinase)IBA 03/2022
1	InflammasomesIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Lumefantrine FDA Link 11/2021
1	SaltsIBA 11/2021
1	carbopol 940 (sodium polyacrylate)IBA 11/2021
1	3-nitropropionic acidIBA 09/2021
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 09/2021
1	chondroitin sulfate proteoglycan 4IBA 09/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2021
1	glutaryl-coenzyme A (glutaryl-CoA)IBA 07/2021
1	Oxidoreductases (Dehydrogenase)IBA 07/2021
1	RANK LigandIBA 07/2021
1	pitavastatin (itavastatin)FDA Link 07/2021
1	Anabolic AgentsIBA 07/2021
1	trovafloxacinIBA 05/2021
1	Sorafenib (BAY 43-9006)FDA Link 05/2021
1	lenvatinibIBA 05/2021
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2021
1	Guanosine Triphosphate (GTP)IBA 01/2021
1	2,4-dinitrobenzeneIBA 01/2021
1	OxygenasesIBA 01/2021
1	RNA Precursors (Precursor, mRNA)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 09/2020
1	2,4-dinitrobenzenesulfonic acidIBA 09/2020
1	4-phenylbutyric acid (Buphenyl)FDA Link 09/2020
1	4-phenylbutylamineIBA 09/2020
1	NestinIBA 09/2020
1	InterferonsIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	ametantrone (HAQ)IBA 01/2020
1	Selenium-Binding ProteinsIBA 01/2020
1	mepenzolic acid (Cantil)FDA Link 01/2020
1	DinitrobenzenesIBA 12/2019
1	sofalcone (Solon)IBA 12/2019
1	Mesalamine (Mesalazine)FDA LinkGeneric 11/2019

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2016
1	Ligation 01/2022
1	Ovariectomy (Oophorectomy) 07/2021
1	Self Administration (Administration, Self) 01/2021
1	Transition to Adult Care 01/2021
1	Rectal Administration 12/2019